QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 专题：西安交通大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway. 期刊论文 American journal of translational research, 2018, 卷号: 10, 页码: 3542-3554 作者:  Zhang Nan;  Wei Zhu-Liang;  Yin Jing;  Zhang Lu;  Wang Jin 收藏  |  浏览/下载：12/0  |  提交时间：2019/11/26 miR-106a*  apoptosis  methyl-CpG binding protein 2 (MeCP2)  proliferation  Oral squamous cell carcinoma (OSCC)   MiR-106a*inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/beta-Catenin signaling pathway 期刊论文 AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 卷号: 10, 页码: 3542-3554 作者:  Zhang, Nan;  Wei, Zhu-Liang;  Yin, Jing;  Zhang, Lu;  Wang, Jin 收藏  |  浏览/下载：14/0  |  提交时间：2019/11/26 miR-106a*  apoptosis  methyl-CpG binding protein 2 (MeCP2)  proliferation  Oral squamous cell carcinoma (OSCC)   Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases 期刊论文 MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 卷号: 399, 期号: [db:dc_citation_issue], 页码: 244-249 作者:  Song, Rong-hua;  Qin, Qiu;  Yan, Ni;  Muhali, Fatuma-said;  Meng, Shuai 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/02 Single nucleotide polymorphism (SNP)  Methyl-CpG-binding protein 2 (MECP2)  Autoimmune thyroid disease (AITD)  Interleukin-1 receptor-associated kinase 1 (IRAK1)  Graves' disease (GD)  Hashimoto's thyroiditis (HT)   MECP2 PROMOTES CELL PROLIFERATION BY ACTIVATING ERK1/2 AND INHIBITING p38 ACTIVITY IN HUMAN HEPATOCELLULAR CARCINOMA HEPG2 cells 期刊论文 CELLULAR AND MOLECULAR BIOLOGY, 2013, 卷号: 59, 期号: [db:dc_citation_issue], 页码: 1876-1881 作者:  Zhao, L. Y.;  Zhang, J.;  Guo, B.;  Yang, J.;  Han, J. 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/10 cell cycle  Methyl CpG-binding protein  proliferation  Hepatocellular carcinoma  mitogen-activated protein kinases